Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
FEBS Letters|April 15, 2014
Wild type p53 reactivation: from lab bench to clinicGalina Selivanova
Current Cancer Drug Targets|August 24, 2004
p53: fighting cancerGalina Selivanova
Seminars in Cancer Biology|March 9, 2010
Therapeutic targeting of p53 by small moleculesGalina Selivanova
Cancers|October 13, 2021
p53-Dependent Repression: DREAM or Reality?Sylvain Peuget, Galina Selivanova
Discovery Medicine|August 14, 2010
Rescue of the p53 tumor suppressor by a rationally designed moleculeGalina Selivanova, Alan Fersht
Cell|January 13, 2010
Integrins and mutant p53 on the road to metastasisGalina Selivanova, Johanna Ivaska
Cancer Discovery|May 4, 2023
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 ReactivationSylvain Peuget, Galina Selivanova
Cell Cycle (Georgetown, Tex.)|September 25, 2003
Inhibition of p53 activity in vitro and in living cells by a synthetic peptide derived from its core domainMarina Protopopova, Galina Selivanova
Nature Reviews. Cancer|January 29, 2024
Translating p53-based therapies for cancer into the clinicSylvain Peuget, Xiaolei Zhou, Galina Selivanova
Experimental Cell Research|December 17, 2008
Tumor-specific induction of apoptosis by a p53-reactivating compoundElisabeth Hedström, Natalia Issaeva, Martin Enge, et al.
Pageof 6